M. D. Green

Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer

M. D. Green, Prudence A. Francis, Val Gebski et al. · Annals of Oncology · 2009 · 63 citations · Full text

Medicine, Oncology, Pharmacology +12

Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia

Mark Rosenthal, Danny Rischin, Grant A. McArthur et al. · Annals of Oncology · 2002 · 63 citations · Full text

Medicine, Hematology, Pharmacology +8

Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer

Jürg Bernhard, David Zahrieh, J. J. Zhang et al. · British Journal of Cancer · 2007 · 23 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up

Marco Colleoni, Zijie Sun, Giovanni Martinelli et al. · Annals of Oncology · 2009 · 19 citations · Full text

Medicine, Endocrinology, Oncology +13

PRIMARY CEREBRAL LYMPHOMA: AN ARGUMENT FOR THE USE OF ADJUNCTIVE SYSTEMIC CHEMOTHERAPY

Mark Rosenthal, W. P. Sherldan, M. D. Green et al. · Australian and New Zealand Journal of Surgery · 1993 · 12 citations

Medicine, Oncology, Chemotherapy +7